Literature DB >> 12039885

Resistance to macrolides in clinical isolates of Streptococcus pyogenes due to ribosomal mutations.

Brigitte Malbruny1, Kensuke Nagai, Maëlle Coquemont, Bülent Bozdogan, Arjana Tambic Andrasevic, Helena Hupkova, Roland Leclercq, Peter C Appelbaum.   

Abstract

OBJECTIVE: Two clinical strains of Streptococcus pyogenes, 237 and 544, one isolated in Slovakia and the other in Croatia, that were resistant to azithromycin (MIC 8 and 2 mg/L, respectively) but susceptible to erythromycin (MIC 0.5 and 0.12 mg/L, respectively) did not contain any gene known to confer macrolide resistance by ribosomal modification (erm gene) or efflux [mef(A) and msr(A) genes]. The aim of the study was to determine the mechanisms of macrolide resistance in both strains.
METHODS: Portions of genes encoding ribosomal proteins L22 and L4, and 23S rRNA (domains II and V) in the two macrolide-resistant strains and in control strains susceptible to macrolides, were analysed by PCR and single-strand conformational polymorphism, to screen for mutations. The DNA sequences of amplicons from resistant strains that differed from those of susceptible strains, in terms of their electrophoretic migration profiles, were determined.
RESULTS: S. pyogenes 237 displayed a KG insertion after position 69 in ribosomal protein L4. S. pyogenes 544 contained a C2611U mutation in domain V of 23S rRNA.
CONCLUSION: Mutations at a similar position in ribosomal protein L4 and 23S rRNA have been reported previously in macrolide-resistant pneumococci. This report shows that similar mutations can be found in macrolide-resistant S. pyogenes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12039885     DOI: 10.1093/jac/dkf038

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  22 in total

1.  Macrolide resistance determinants of invasive and noninvasive group B streptococci in a Turkish hospital.

Authors:  Ziya Cibali Acikgoz; Ebru Almayanlar; Sohret Gamberzade; Safiye Gocer
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

2.  Mutations in a 23S rRNA gene of Chlamydia trachomatis associated with resistance to macrolides.

Authors:  O Y Misyurina; E V Chipitsyna; Y P Finashutina; V N Lazarev; T A Akopian; A M Savicheva; V M Govorun
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

3.  Ribosomal mutations in Arcanobacterium pyogenes confer a unique spectrum of macrolide resistance.

Authors:  B Helen Jost; Hien T Trinh; J Glenn Songer; Stephen J Billington
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

4.  In vitro subminimum inhibitory concentrations of macrolide antibiotics induce macrolide resistance in Mycoplasma pneumoniae.

Authors:  G Ou; Y Liu; Y Tang; X You; Y Zeng; J Xiao; L Chen; M Yu; M Wang; C Zhu
Journal:  Hippokratia       Date:  2015 Jan-Mar       Impact factor: 0.471

5.  Evolution and global dissemination of macrolide-resistant group A streptococci.

Authors:  D Ashley Robinson; Joyce A Sutcliffe; Wezenet Tewodros; Anand Manoharan; Debra E Bessen
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

6.  Association between resistance to erythromycin and the presence of the fibronectin binding protein F1 gene, prtF1, in Streptococcus pyogenes isolates from German pediatric patients.

Authors:  Maria Haller; Kirsten Fluegge; Sandra Jasminder Arri; Brit Adams; Reinhard Berner
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

7.  In vitro activities of novel 2-fluoro-naphthyridine-containing ketolides.

Authors:  Darren Abbanat; Glenda Webb; Barbara Foleno; Y Li; Mark Macielag; Deborah Montenegro; Ellyn Wira; Karen Bush
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

8.  Resistance to erythromycin and telithromycin in Streptococcus pyogenes isolates obtained between 1999 and 2002 from Greek children with tonsillopharyngitis: phenotypic and genotypic analysis.

Authors:  Ioanna N Grivea; Adnan Al-Lahham; George D Katopodis; George A Syrogiannopoulos; Ralf René Reinert
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

9.  A global map of genetic diversity in Babesia microti reveals strong population structure and identifies variants associated with clinical relapse.

Authors:  Jacob E Lemieux; Alice D Tran; Lisa Freimark; Stephen F Schaffner; Heidi Goethert; Kristian G Andersen; Suzane Bazner; Amy Li; Graham McGrath; Lynne Sloan; Edouard Vannier; Dan Milner; Bobbi Pritt; Eric Rosenberg; Sam Telford; Jeffrey A Bailey; Pardis C Sabeti
Journal:  Nat Microbiol       Date:  2016-06-13       Impact factor: 17.745

Review 10.  Resistance to Macrolide Antibiotics in Public Health Pathogens.

Authors:  Corey Fyfe; Trudy H Grossman; Kathy Kerstein; Joyce Sutcliffe
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.